160
Views
3
CrossRef citations to date
0
Altmetric
PHARMACEUTICAL ANALYSIS

A SPE-LC-MS/MS Method for the Detection of Low Concentrations of Pharmaceuticals in Industrial Waste Streams

, , , , &
Pages 2808-2820 | Received 07 Sep 2010, Accepted 14 Jan 2011, Published online: 05 Dec 2011

REFERENCES

  • Armenta , S. , S. Garrigues and M. de la Guardia . 2008 . Green analytical chemistry . Trends Anal. Chem. 27 : 497 – 511 .
  • Ashiru , D. , R. Patel , and A. Basit . 2007. Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine and nizatidine in urine: Application to the analysis of ranitidine and its metabolites in human volunteers. J. Chromatogr. B 860: 235–240.
  • Boehringer Ingelheim (Canada) Ltd. 2008 . Product Monograph Flomax® CR.
  • Barron , L. , J. M. Tobin , and B. Paul . 2008 . Multi-residue determination of pharmaceuticals in sludge and sludge enriched soils using pressurized liquid extraction, solid phase extraction and liquid chromatography with tandem mass spectrometry . J. Environ. Monit. 10 : 353 – 361 .
  • Basha , S. , D. Keane , A. Morrissey , K. Nolan , M. Oelgemöller , and J. Tobin . 2010 . Studies on the adsorption and kinetics of photodegradation of pharmaceutical compound, indomethacin using novel photocatalytic adsorbents (IPCAs) . Ind. Eng. Chem. Res. 49 : 11302 – 11309 .
  • Castiglioni , S. , R. Bagnati , R. Fanelli , F. Pomati , D. Calamari , and E. Zuccato . 2006 . Removal of Pharmaceuticals in Sewage Treatment Plants in Italy . Environ. Sci. Technol. 40 : 357 – 363 .
  • Deegan , A.-M. , S. Basha , K. Nolan , K. Urell , M. Oelgemöller , J. Tobin , and A. Morrissey . 2011 . Treatment options for wastewater effluents from pharmaceutical companies . Internat. J. Environ. Sci. Technol. 8 : 649 – 666 .
  • Gómez , M. J. , M. M. Gómez-Ramos , O. Malato , M. Mezcua , and A. R. Férnandez-Alba . 2010 . Rapid automated screening, identification and quantification of organic micro-contaminants and their main transformation products in wastewater and river waters using liquid chromatography–quadrupole-time-of-flight mass spectrometry with an accurate-mass database . J. Chromatogr. A 1217 : 7038 – 7054 .
  • Grujić , S. , V. Tatjana , and M. Laušević . 2009 . Determination of multiple pharmaceutical classes in surface and ground waters by liquid chromatography–ion trap–tandem mass spectrometry . J. Chromatogr. 1216 : 4989 – 5000 .
  • Helmig , E. , J. Fettig , and L. Cordone . 2007 . API Removal from pharmaceutical manufacturing wastewater – results of process development, pilot-testing, and scale-up WEF session, Rhode Island, July, 2007.
  • Heberer , T. 2002 . Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data . Toxicol. Lett. 131 : 5 – 17 .
  • Jelić , A. , M. Petrović , and D. Barceló . 2009 . Multi-residue method for trace level determination of pharmaceuticals in solid samples using pressurized liquid extraction followed by liquid chromatography/quadrupole-linear ion trap mass spectrometry . Talanta 80 : 363 – 371 .
  • Keane , K. , S. Basha , K. Nolan , A. Morrissey , M. Oelgemöller , and J. Tobin . 2011 . Photodegradation of famotidine by integrated photocatalytic adsorbent (IPCA) and kinetic study . Catal. Lett. 141 : 300 – 308 .
  • Keski-Rahkonen , P. , O. Pärssinen , E. Leppänen , T. Mauriala , M. Lehtonen , and S. Auriola . 2007 . Determination of tamsulosin in human aqueous humor and serum by liquid chromatography-electrospray ionization tandem mass spectrometry . J. Pharm. Biomed. Anal. 43 : 606 – 612 .
  • Khetan , S. , and T. Collins . 2007 . Human pharmaceuticals in the aquatic environment: A challenge to green chemistry . Chem. Rev. 107 : 2319 – 2364 .
  • Kim , S. , J. Cho , I. Kim , B. Vanderford , and S. Snyder . 2007 . Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and wastewaters . Water Res. 41 : 1013 – 1021 .
  • Kobayashi , D. , T. Nozawa , K. Imai , J. I. Nezu , A. Tsuji , and I. Tamai . 2007 . Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane . J. Pharm. Sci. 10 : 358 – 367 .
  • Kummerer , K. 2004 . Resistance in the environment . J. Antimicrob. Chemother. 54 : 311 – 32 .
  • Lacey , C. , G. McMahon , J. Bones , L. Barron , A. Morrissey , and J. Tobin . 2008 . An LC-MS method for the determination of pharmaceutical compounds in wastewater treatment plant influent and effluent samples . Talanta 75 : 1089 – 1097 .
  • Larsen , T. A. , J. Lienert , A. Joss , and H. Siegrist . 2004. How to avoid pharmaceuticals in the aquatic environment. J. Biotechnol. 113: 295–304.
  • Larsson , D. , M. Adolfsson-Erici , J. Parkkonen , M. Pettersson , A. Berg , P. Olsson , and L. Förlin . 1999 . Ethinyloestradiol — an undesired fish contraceptive? Aquat. Toxicol. 45 : 91 – 97 .
  • Larsson , D. , C. de Pedro , and N. Paxeus . 2007 . Effluent from drug manufactures contains extremely high levels of pharmaceuticals . J. Hazard. Mater. 148 : 751 – 755 .
  • López-Roldán , R. , M. López de Alda , M. Gros , M. Petrovic , J. Martín-Alonso , and D. Barceló . 2010 . Advanced monitoring of pharmaceuticals and estrogens in the Llobregat River basin (Spain) by liquid chromatography–triple quadrupole-tandem mass spectrometry in combination with ultra performance liquid chromatography–time of flight-mass spectrometry . Chemosphere . 80 : 1337 – 1344 .
  • Maniscalco , M. , D. Singh-Franco , W. Wolowich , and R. Torres-Colón . 2006 . Solifenacin succinate for the treatment of symptoms of overactive bladder . Clin. Ther. 28 : 1247 – 1272 .
  • Mistri , H. , A. Jangid , A. Pudage , D. Rathod , and P. Shrivastav . 2008 . Highly sensitive and rapid LC-ESI-MS/MS method for the simultaneous quantification of uroselective α1-blocker, alfuzosin and an antimuscarinic agent, solifenacin in human plasma . J. Chromatogr. B 876 : 236 – 244 .
  • Mompelat , S. , B. Le Bot , and O. Thomas . 2009 . Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water . Environ. Int. 35 : 803 – 814 .
  • Oaks , J. , M. Gilbert , M. Virani , R. Watson , C. Meteyer , B. Rideout , et al. . 2004 . Diclofenac residues as the cause of vulture population decline in Pakistan . Nature 427 : 630 – 633 .
  • Petrovic , M. , M. Gros , and D. Barcelo . 2006 . Multi-residue analysis of pharmaceuticals in wastewater by ultra-performance liquid chromatography–quadrupole–time-of-flight mass spectrometry . J. Chromatogr. A 1124 : 68 – 81 .
  • Santos , J. , I. Aparicio , and E. Alonso . 2007 . Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain) . Environ. Int. 33 : 596 – 601 .
  • Schwartz , T. , W. Kohnen , B. Jansen , and U. Obst . 2003 . Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms . FEMS Microb. Ecol. 43 : 325 – 335 .
  • Simpson , N. 2000 . Solid-phase extraction: Principles, techniques and applications . California : CRC Press .
  • Wick , A. , G. Fink , A. Joss , H. Siegrist , and T. Ternes . 2009 . Fate of beta blockers and psycho-active drugs in conventional wastewater treatment . Water Res. 43 : 1060 – 1074 .
  • Zhong , L. , R. Eisenhandler , and Y. Kuang . 2001 . Determination of Famotidine in low-volume human plasma by normal-phase liquid chromatography/tandem mass spectrometry . J. Mass Spectrom. 77 : 736 – 741 .
  • Zorita , S. , L. Mårtensson , and L. Mathiasson . 2009 . Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden . Sci. Total Environ. 407 : 2760 – 2770 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.